Novo Nordisk | NVO - Capitalización De Mercado

Precio De Mercado
41.17
Cambio Diario
-0.01 -0.02%
Mensual
16.70%
Anual
-36.80%
Q2 Expectativa
39.20




Capitalización De Mercado Cambio Fecha
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Bausch Health Companies USD 2.58B 194.9M 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 234.78B 72.98B 2026-04
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Zoetis USD 55.45B 9.4B 2025-12